New combo therapy targets high-risk lymphoma patients
NCT ID NCT04980222
First seen Nov 18, 2025 · Last updated Apr 29, 2026 · Updated 23 times
Summary
This study tests a new drug, glofitamab, added to standard chemotherapy (R-CHOP) for people with a fast-growing type of lymphoma that has a high risk of coming back. The goal is to see if the combination is safe and works better at controlling the cancer. About 46 adults with untreated diffuse large B-cell lymphoma will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aarhus Universitetshospital Skejby
Aarhus N, 8200, Denmark
-
Baylor University Medical Center
Dallas, Texas, 75204, United States
-
Centre Henri Becquerel
Rouen, 76038, France
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hospital Clinic i Provincial de Barcelona
Barcelona, 08036, Spain
-
Hospital Clinico Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital General Universitario Gregorio Marañon
Madrid, 28007, Spain
-
Hospital Univ. 12 de Octubre; Servicio de Hematologia
Madrid, 28041, Spain
-
Memorial Sloan Kettering Bergen
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center at Westchester
Harrison, New York, 10604, United States
-
Stanford Cancer Center
Stanford, California, 94305-5820, United States
-
Universitair Medisch Centrum Groningen
Groningen, 9713 GZ, Netherlands
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
Uniwersytecki Szpital Kliniczny; Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
Wroclaw, 50-367, Poland
-
Uniwersyteckie Centrum Kliniczne, Klinika Hematologii i Transplantologii
Gdansk, 80-211, Poland
-
Washington University; Wash Uni. Sch. Of Med
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.